Last Friday (4/23), the CDC’s Advisory Committee on Immunization Practices (ACIP), reviewed 15 cases of rare blood clots, thrombosis with thrombocytopenia syndrome (TTS), that occurred following administration of the Janssen (Johnson & Johnson) COVID-19 vaccine.
ACIP voted 10-4 to recommend lifting the temporary, 10-day pause of use of the J&J vaccine. Following that recommendation, CDC and FDA lifted the pause.
Tomorrow (4/27), CDC’s Clinician Outreach and Communication Activity (COCA) Call will discuss information on TTS and updated vaccine recommendations. This webinar is scheduled for Tuesday, April 27 from 2:00 - 3:00pm Eastern Time.Click here to join the 4/27 CDC Meeting
These TTS cases were detected through the Vaccine Adverse Events Reporting System (VAERS). Reminder that healthcare providers are required by law to report any adverse event to VAERS.